Equities

Cathay Biotech Inc

688065:SHH

Cathay Biotech Inc

Actions
Basic MaterialsChemicals
  • Price (CNY)32.80
  • Today's Change-0.20 / -0.61%
  • Shares traded860.74k
  • 1 Year change-40.37%
  • Beta--
Data delayed at least 15 minutes, as of Sep 23 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5,0146,2269,629
Total Receivables, Net672556514
Total Inventory1,4661,5741,185
Prepaid expenses415167
Other current assets, total37770--
Total current assets7,5718,47511,395
Property, plant & equipment, net10,2468,3743,907
Goodwill, net------
Intangibles, net704778768
Long term investments1435053
Note receivable - long term------
Other long term assets5.9055--
Total assets18,83317,82716,185
LIABILITIES
Accounts payable1,6521,060290
Accrued expenses251924
Notes payable/short-term debt776161755
Current portion long-term debt/capital leases7845.38--
Other current liabilities, total172179148
Total current liabilities3,4101,4241,218
Total long term debt2459610
Total debt1,8061,127755
Deferred income tax------
Minority interest3,6094,0894,022
Other liabilities, total405404293
Total liabilities7,6696,8785,533
SHAREHOLDERS EQUITY
Common stock583583417
Additional paid-in capital8,5268,5408,688
Retained earnings (accumulated deficit)2,1781,9141,546
Treasury stock - common(126)(95)--
Unrealized gain (loss)------
Other equity, total3.655.941.50
Total equity11,16410,94910,652
Total liabilities & shareholders' equity18,83317,82716,185
Total common shares outstanding583583583
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.